Legislative Research: WI AB1134 | 2023-2024 | Regular Session
Other Sessions
| Session | Title/Description | Last Action |
|---|---|---|
| 2023-2024 Regular Session (Failed) | An Act to create 146.901 of the statutes; Relating to: prescription drug cost reporting by manufacturers and providing a penalty. [AB1134 2023 Detail][AB1134 2023 Text][AB1134 2023 Comments] | 2024-04-15 Failed to pass pursuant to Senate Joint Resolution 1 |
| 2021-2022 Regular Session (Failed) | An Act to repeal 27.01 (8) (bn), 27.01 (8) (c) 2. and 3., 27.01 (8m) (a) 1., 27.01 (8m) (b) and 27.01 (9) (c); to renumber 27.01 (8) (c) 1.; to consolidate, renumber and amend 27.01 (8m) (a) (intro.) and 2.; to amend 27.01 (8) (a), 27.01 (8) (b) (int... [AB1134 2021 Detail][AB1134 2021 Text][AB1134 2021 Comments] | 2022-04-27 Fiscal estimate received |
References Online
Legislative Citation
APA
WI AB1134 | 2023-2024 | Regular Session. (2024, April 15). LegiScan. Retrieved May 12, 2024, from https://legiscan.com/WI/bill/AB1134/2023
MLA
"WI AB1134 | 2023-2024 | Regular Session." LegiScan. LegiScan LLC, 15 Apr. 2024. Web. 12 May. 2024. <https://legiscan.com/WI/bill/AB1134/2023>.
Chicago
"WI AB1134 | 2023-2024 | Regular Session." April 15, 2024 LegiScan. Accessed May 12, 2024. https://legiscan.com/WI/bill/AB1134/2023.
Turabian
LegiScan. WI AB1134 | 2023-2024 | Regular Session. 15 April 2024. https://legiscan.com/WI/bill/AB1134/2023 (accessed May 12, 2024).
